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Introduction
Glomus tumor is a neoplasm composed of cells that 
resemble the perivascular modified smooth muscle cells of 
the glomus body (1). Although glomus tumors usually arise 
in the subungual region, they may occur elsewhere in the 
body (2). Glomus tumors in the duodenum are rare, and 
only four case reports have been published in the English 
medical literature (3-6) (Table 1). Here, we report a surgically 
confirmed case of glomus tumor originating from the 
duodenum and describe the characteristic imaging findings.
Case presentation
A 42-year-old man was admitted to our medical institution 
with right upper quadrant abdominal pain for 1 month. 
The patient had an episode of melena 3 months before 
the admission. He had no history of surgeries. The 
physical examination was unremarkable. Laboratory 
hematologic and coagulation tests on admission revealed 
no abnormalities. Tumor markers were within the normal 
range: carcinoembryonic antigen, 1.97 ng/mL and 
carbohydrate antigen 19-9, 5.7 U/mL. 
On ultrasonography (US), a well-circumscribed 
hypoechoic mass was seen in the duodenum, measuring 
2.0 cm × 1.7 cm (Figure 1). Unenhanced computed 
tomography (CT) demonstrated hypoattenuating mass in 
the third portion of the duodenum, measuring 2.5 cm × 
1.7 cm (Figure 2A). The mass showed strong enhancement 
with a well-defined margin in the arterial phase (Figure 2B) 
and persistent enhancement in the portal and delayed 
phases (Figure 2C,D). Lesion-to-aorta enhancement 
ratios were 0.62, 0.91, and 0.84 in the arterial, portal, and 
delayed phases, respectively. Coronal arterial phase CT 
demonstrated central ulceration (Figure 2E). No obvious 
metastases or intra-abdominal lymphadenopathies were 
identified.  
The pat ient  underwent  a  l aparoscopic  wedge 
resection of the tumor. Grossly, the tumor was a well-
circumscribed intramural mass, measuring 2.5 cm × 1.5 cm. 
Microscopically, the mass involved the submucosa and 
muscularis propria (Figure 3A). On hematoxylin and eosin 
staining, the tumor was composed of uniform cells with 
round nuclei (Figure 3B). No nuclear atypia was seen, 
and the mitotic count was 0/50 high-power fields (HPF). 
No lymphovascular or perineural invasion was identified. 
Immunohistochemically, the tumor cells were positive for 
smooth muscle actin and collagen IV (Figure 3C,D) but 
negative for chromogranin A (Figure 3E). Synaptophysin 
was focally positive in the tumor cells (Figure 3F). 
Finally, the mass was diagnosed as a glomus tumor of the 
duodenum. The patient had an uneventful postoperative 
course and has remained free from the disease for a follow-
up period of 18 months.
Discussion
Glomus tumor is a mesenchymal tumor arising from the 
perivascular modified smooth muscle cells of the glomus 
body (1). Gastrointestinal glomus tumors are rare but most 
frequently occur in the stomach as a subepithelial tumor (7). 
Epigastric discomfort is the most common symptom (8). 
Gastrointestinal glomus tumors often present with 
gastrointestinal bleeding because of ulcerations in the 
overlying mucosa (9).
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Sonographic and CT findings of gastric glomus tumors 
have been described in the literature. On transabdominal 
or endoscopic ultrasound, they appear as well-demarcated 
hypoechoic masses originating from the third or fourth layer 
of the gastric wall (10-13). On CT, gastric glomus tumors 
show high enhancement in the arterial phase, which reflects 
their hypervascular nature. In the portal and delayed phases, 
the tumor shows persistent enhancement (9,14-16). Gastric 
glomus tumors are more strongly enhanced than other well-
enhancing subepithelial lesions, such as neuroendocrine 
tumor, some gastrointestinal stromal tumor (GIST), 
and heterotopic pancreas (5). In a study by Hur et al., 
lesion-to-aorta enhancement ratios of glomus tumors were 
significantly higher than those of other subepithelial lesions 
in the arterial, portal, and delayed phases (5). In addition, 
the portal phase lesion-to-aorta ratio 0.86 or greater was 
significant variable for differentiating glomus tumors from 
other subepithelial lesions (5). In our case of the duodenal 
glomus tumor, imaging features were similar to those 
previous reported for glomus tumors, showing a lesion-to-
aorta enhancement ratio of 0.91 in the portal phase.
Immunohistochemical f indings are valuable for 
distinguishing glomus tumors from other subepithelial 
tumors (7). Gastrointestinal glomus tumors are positive 
for smooth muscle actin, vimentin, and collagen IV (7). 
Neuroendocrine tumors are positive for chromogranin A 
and synaptophysin (1). Glomus tumors are negative for 
chromogranin A, but there can be focal synaptophysin 
expression (1). GISTs are positive for KIT (CD117) and 
frequently positive for CD34 while glomus tumors are 
persistently negative for CD117 and occasionally positive 
for CD34 (7). 
Although most cases of gastrointestinal glomus tumors 
are benign, cases of malignant behavior and metastases have 
been reported (7,17-19). Folpe et al. proposed the criteria 
for malignant glomus tumors, including tumors with a deep 






Microscopic findings Immunohistochemistry Treatment Reference
1 2004 M 46 2.3 cm Duodenal 
second  
portion
Uniform cells with well-defined cell borders, 
central punched-out nuclei, and faintly staining 
or clear cytoplasm; no necrosis, mitosis, or  
vascular invasion
SMA (+), Vimentin (+),  
Synaptophysin (+/−),  
Cytokeratin AE1/3 (−),  





2 2007 M 65 NR Duodenal 
bulb
Monomorphic cell clusters with monomorphic 
nuclei and eosinophilic cytoplasm
SMA (−), CD34 (−),  




3 2011 NR NR <5 cm NR NR NR NR (5)
4 2016 F 88 2.1 cm Duodenal 
bulb
NR SMA (+), Myosin (+),  
Synaptophysin (+)  
Chromogranin (−),  
CD34 (−), CD56 (−)
NR (6)
5 2019 M 42 2.5 cm Duodenal 
third  
portion
Uniform cells with round nuclei SMA (+), Collagen IV (+),  






SMA, smooth muscle actin; (+/−), focal positive in immunohistochemistry; NR, not reported. 
Figure 1 The duodenal glomus tumor shows a well-circumscribed 
hypoechoic mass on ultrasonography. 
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location and a size greater than 2 cm, or atypical mitotic 
figures, or moderate-to-high nuclear grade, and ≥5 mitotic 
figures/50 HPF (18).
In conclusion, we reported a rare case of a glomus 
tumor arising in the duodenum. The characteristic strong 
and persistent enhancement on CT may be useful in 
differentiating glomus tumors from other subepithelial 
lesions.
Figure 2 Computed tomography of the duodenal glomus tumor. Axial unenhanced computed tomography (CT) scan (A) shows a well-
circumscribed mass (arrow) in the third portion of the duodenum. Contrast-enhanced CT scans reveal strong enhancement in the arterial 
phase (B) and persistent enhancement in the portal (C) and delayed (D) phases (arrows). Coronal arterial phase CT scan (E) demonstrates 
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Figure 3 Histopathology of the duodenal glomus tumor. (A) The tumor involved the submucosa and muscularis propria (×40); (B) 
hematoxylin and eosin (H&E) staining showed uniform small round cells with central nuclei and pale cytoplasm, no nuclear atypia, and no 
mitotic figures (×400); (C,D) immunohistochemical staining showed positive expression for smooth muscle actin and collagen IV (×40); (E,F) 
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